Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

…, Y Nakamura, N Enomoto, K Ide, M Toyoshima… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To assess the difference in clinical features and prognosis of patients with
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…

[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease

…, N Inui, K Yokomura, N Koshimizu, M Toyoshima… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …

Interstitial lung diseases associated with amyopathic dermatomyositis

…, D Hashimoto, J Sato, M Toyoshima… - European …, 2006 - Eur Respiratory Soc
The aim of the present study was to clarify the clinical characteristics and prognosis of
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…

Alterations in smoking habits are associated with acute eosinophilic pneumonia

…, M Shirai, H Gemma, T Shirai, M Toyoshima… - Chest, 2008 - Elsevier
Background Acute eosinophilic pneumonia (AEP) is characterized by a febrile illness, diffuse
pulmonary infiltrates, and pulmonary eosinophilia. The etiology of AEP remains unknown, …

Bronchiolar disease in rheumatoid arthritis.

…, A Sato, S Imokawa, M Toyoshima… - American journal of …, 1996 - atsjournals.org
The pulmonary manifestations of rheumatoid arthritis (RA) include bronchiolar diseases
such as follicular bronchiolitis (FB) and bronchiolitis obliterans (BO). In this study, we …

A clinical study of idiopathic eosinophilic pneumonia

H Hayakawa, A Sato, M Toyoshima, S Imokawa… - Chest, 1994 - Elsevier
To better characterize idiopathic eosinophilic pneumonia (IEP), we studied the clinical and
laboratory features of 27 patients. Patients with IEP could be divided into those with chronic …

Efficacy of Clarithromycin and Ethambutol for Mycobacterium avium Complex Pulmonary Disease. A Preliminary Study

S Miwa, M Shirai, M Toyoshima, T Shirai… - Annals of the …, 2014 - atsjournals.org
Rationale: Patients with Mycobacterium avium complex pulmonary disease are frequently
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …

[HTML][HTML] Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study

…, K Yokomura, N Koshimizu, M Toyoshima… - Respiratory …, 2017 - Elsevier
Background Although the accurate diagnosis of pleuroparenchymal fibroelastosis (PPFE)
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …

[HTML][HTML] Assessment of immune-related interstitial lung disease in patients with NSCLC treated with immune checkpoint inhibitors: a multicenter prospective study

…, M Kato, H Matsuda, S Matsuura, M Toyoshima… - Journal of Thoracic …, 2020 - Elsevier
Introduction Programmed cell death protein 1 immune checkpoint inhibitors (ICIs) have
been reported to improve the survival of patients with NSCLC. On the expansion of clinical …

Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

…, K Yokomura, N Koshimizu, M Toyoshima… - …, 2021 - Wiley Online Library
Background and objective The efficacy of combination therapy with corticosteroids and CNI,
TAC and CsA, for PM/DM‐ILD has been described retrospectively. However, it remains …